One of Australia’s largest industry funds has lifted its venture capital allocation to $100 million, ignoring fears about ...

Abbott India Dividend: In a big boost for its company shareholders, Abbott India announced a bumper final dividend of Rs 475 ...

European shares rounded off their fifth week of gains on Friday, as trade deals out of the U.S. eased tariff worries and strong corporate results provided further boost. The region-wide STOXX 600 ...

After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.

The "Biopharmaceutical Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.The Global Biopharmaceutical ...

These drugs target some of the most pressing cancer types, including multiple myeloma, breast cancer, and bladder cancer ...

The use of stereotactic body radiotherapy (SBRT) as salvage therapy after radical prostatectomy was well tolerated, with no ...

GlobalData analysts have tipped the global market for genomic therapies to balloon to almost $90 billion by 2030, driven by ...

Concerns are being raised over plans to build hundreds of new houses and flats on land in Horsham that is feared could be ...

The Novartis oncology strategy focuses on people living with cancer and those who care for them, from loved ones to clinical care teams, including their providers. For the past 30+ years, the aim has ...

Procter & Gamble, Nestlé, Apple, L'Oréal, Novartis, LG Electronics and Unilever among the largest portfolio owners in most registers LONDON, May 15, 2025 /PRNewswire/ -- Clarivate Plc ...

Polanco, executive VP and chief commercial officer, Novartis US, and the 2025 Healthcare Businesswomen’s Association Woman of ...